Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

  • ESTA - Electronic System for Travel Authorization
Receive Latest News

Share Us

3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance

View: 198

Website | Edit Freely


Deadline: June 01, 2018 | Date: June 01, 2018

Venue/Country: Online, U.S.A

Updated: 2018-05-03 21:29:05 (GMT+9)

Call For Papers - CFP

3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance

Time: 12:00 PM EDT | 9:00 AM PDT | 11:00 PM CDT Duration 180 Minutes


A premarket notification (510(k)) is required when a legally marketed device subject to 510(k) requirements is about to be significantly changed or modified in design, components, method of manufacture, or intended use. Significant changes or modifications are those that could significantly affect the safety or effectiveness of the device, or major changes or modifications in the intended use of the device (21 CFR 807.81(a)(3)).

This presentation, will aid manufacturers of medical devices who intend to modify a 510(k)-cleared device or a preamendments device subject to 510(k) (i.e., “existing devices”) during the process of deciding whether the modification exceeds the regulatory threshold of 21 CFR 807.81(a)(3) for submission and clearance of a new 510(k).

Why should you attend

This presentation uses the latest FDA thinking and guidance documents to assist the manufacturers in enhancing the predictability, consistency, and transparency of the “when to submit” decision-making process by providing a least burdensome approach, and describing in greater detail the regulatory framework, policies, and practices underlying such a decision.

Case Study Examples will be provided for each session to further assist the attendees in understanding how to decide when to submit a 510(k) for a change to an existing device.

Who will Benefit

• Quality Managers

• Quality Engineers

• Regulatory Affairs

• Small business owners

• GxP

• Consultants

• Quality VPs

• IT VPs

• Lab Directors

• Scientists

• FDA investigators

• Other regulatory agency investigators

Industries who can attend

Learning Objectives:

1. The main types of changes that might be made to a device

2. Labeling changes

3. Technology, engineering, and performance changes

4. Materials changes

5. Technology, engineering, performance, and materials changes for in vitro diagnostic devices (IVDs)

6. Considerations for risk-based assessments of modified devices

Speaker Profile

Angela Bazigos.CEO of Touchstone Technologies Inc. She has 40 years of experience in the Life Sciences & Healthcare Industries. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety, Turnarounds and Business Development. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers. Positions include Chief Compliance Officer at Morf Media. Co-authored & prototyped 21 CFR 11 guidance with FDA. Co-authored Computerized Systems in Clinical Research w/ FDA. Patent on speeding up software compliance.

Price: $295 One Dial-in One Attendee | Corporate Live Recorded $395 One Dial In - Max 10 attendees |Group $995 Multiple locations upto 5 dial in | Recorded $345

Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.